Every 424B that Innovex International, Inc. (INVX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INVX filings page.
Innovex International, Inc. is facilitating a secondary underwritten resale of 5,000,000 shares of its common stock by existing selling stockholders under a Rule 424(b)(7) prospectus supplement to its shelf registration. Barclays has agreed to purchase the shares from the selling stockholders at $28.71 per share, providing $143,550,000 in proceeds to those stockholders before expenses; Innovex will not receive any proceeds.
As of August 4, 2026, 69,935,827 shares of common stock were outstanding. Amberjack Capital Partners L.P. and its affiliates beneficially own about 33% of Innovex before the offering and are expected to hold about 26% afterward, reducing their right under a stockholders’ agreement to designate board nominees from three to two. The shares are listed on the NYSE under “INVX”; the last reported sale price on August 5, 2026 was $30.44 per share. The company highlights ongoing acquisition activity, a 45‑day lock-up for the company, officers, directors and selling stockholders, and states it does not expect to pay cash dividends in the foreseeable future, instead prioritizing reinvestment, potential repurchases and acquisitions.
Innovex International, Inc. has filed a prospectus supplement for the resale by existing investors of 5,000,000 shares of common stock under an existing shelf registration. All shares are being sold by the selling stockholders; Innovex will not receive any proceeds, while Barclays acts as underwriter.
The common stock trades on the NYSE under the symbol INVX; the last reported sale price on August 4, 2026 was $31.63 per share. The supplement sits on a base shelf covering up to 29,369,822 shares received by these holders in the Innovex Downhole merger, and after this offering the selling stockholders will still hold 17,757,322 registered shares.
Amberjack Capital Partners L.P. and affiliates currently beneficially own about 33% of Innovex’s outstanding common stock and are expected to own about 26% after this sale, while total shares outstanding were 69,935,827 as of August 4, 2026. The company and key holders have agreed to a 45‑day lock‑up on additional sales, subject to customary exceptions.
Innovex International, Inc. is registering 5,750,000 shares of common stock for resale by the selling stockholders.
The company will not receive proceeds from these sales; the selling stockholders will receive the net proceeds at a public offering price of $25.75 per share. The underwriters’ discount is $1.15875 per share. Innovex intends, subject to the offering’s completion, to purchase the lesser of 10% (which would be 575,000 shares) and $15,000,000 of the shares being sold. The underwriters have an option to purchase up to 862,500 additional shares. The last reported sale price on the NYSE was $28.90 per share as of February 24, 2026.
Innovex International, Inc. is registering the resale of 5,750,000 shares of its common stock by selling stockholders as set forth in a preliminary prospectus supplement dated February 25, 2026. The Company will receive no proceeds from these sales and has agreed to register up to 29,369,822 shares for resale under the base prospectus.
The prospectus supplement states the Company intends, subject to completion of the offering, to repurchase the lesser of 10% of the offered shares or $15,000,000 (which would equal 575,000 shares if repurchasing 10%). Shares outstanding were 69,138,690 shares as of February 24, 2026. The underwriters have a 30‑day option to purchase additional shares and lock-up and registration‑rights provisions apply to the selling stockholders and certain insiders.